Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
FDA Clears Abbott's Latest EnSite Heart Mapping Platform
11:56am, Wednesday, 12'th Jan 2022
Abbott Laboratories (NYSE: ABT) has scored clearance from the FDA for its latest 3D cardiac mapping platform, designed to help physicians target abnormal heart rhythms. The EnSite X EP system thr
Upcoming Ex-Dividend Dates: January 13-26, 2022
10:22am, Wednesday, 12'th Jan 2022
Upcoming Ex-Dividend Dates: January 13-26, 2022
Abbott (ABT) Gains But Lags Market: What You Should Know
07:10pm, Tuesday, 11'th Jan 2022
In the latest trading session, Abbott (ABT) closed at $135.70, marking a +0.33% move from the previous day.
Abbott Laboratories (ABT) CEO Robert Ford Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)
04:45pm, Tuesday, 11'th Jan 2022 Seeking AlphaHow to Analyze Dividend Stocks
02:12pm, Tuesday, 11'th Jan 2022
For many investors, dividends are an integral part of investing. Some investors will only buy companies with dividends, and some will only buy companies with high dividend yields compared to the rest
Why Abbott (ABT) Could Beat Earnings Estimates Again
01:50pm, Tuesday, 11'th Jan 2022
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Omicron-specific vaccines are ‘already priced into COVID stocks': Jefferies Managing Director
12:32pm, Tuesday, 11'th Jan 2022
Jefferies Managing Director Michael Yee joins Yahoo Finance Live's Julie Hyman and Brian Sozzi to discuss the biotech sector, outlook for M&A activity, and the outlook for COVID-19 stocks.
Abbott Laboratories (ABT) CEO Robert Ford Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)
11:45am, Tuesday, 11'th Jan 2022
Abbott Laboratories (ABT) CEO Robert Ford Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)
Abbott Labs CEO expects strong COVID-19 testing demand in near term
10:08am, Tuesday, 11'th Jan 2022
Abbott Laboratories Chief Executive Officer Robert Ford said on Tuesday demand for COVID-19 testing has surged globally and that sales of its tests should stay strong in the near term.
3 Top Stock Trades for the Week of Jan. 10, 2022
03:01pm, Monday, 10'th Jan 2022
Sellers continue to push their advantage making it necessary to play defense to win. Here are three top stock trades for the new week.
Abbott Labs rips bad actors reselling COVID tests above retail price
05:13pm, Friday, 07'th Jan 2022 New York Post
Over-the-counter COVID-19 tests are in high demand as the Omicron variant drives a record surge in daily infections.
Abbott Labs rips ‘bad actors' reselling COVID tests above retail price
12:13pm, Friday, 07'th Jan 2022
Over-the-counter COVID-19 tests are in high demand as the Omicron variant drives a record surge in daily infections.
10 Upcoming Dividend Increases Including The 'Abbotts'
10:32pm, Thursday, 06'th Jan 2022
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 7.1% and a median increase of 7.2%. I've tracked
Abbott Lab''s CEO Unveils Wearable Bionsensors at CES
09:40pm, Thursday, 06'th Jan 2022 Barron''s
CEO Robert Ford delivered the first-ever health care keynote at the annual consumer tech trade show in Las Vegas.
Abbott aims to increase production of home COVID tests to 100M per month - Bloomberg
09:24pm, Thursday, 06'th Jan 2022 Seeking Alpha
Abbott Laboratories is aiming to boost its monthly production of BinaxNOW at-home rapid COVID-19 tests from 70M to !100M, Bloomberg reports.
